Free Trial
OTCMKTS:VODG

Vitro Diagnostics (VODG) Stock Price, News & Analysis

Vitro Diagnostics logo
$0.40 0.00 (0.00%)
As of 10/15/2020

About Vitro Diagnostics Stock (OTCMKTS:VODG)

Key Stats

Today's Range
$0.40
$0.40
50-Day Range
$0.40
$0.40
52-Week Range
$0.13
$1.04
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.

Receive VODG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vitro Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

VODG Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

VODG Stock Analysis - Frequently Asked Questions

Vitro Diagnostics' stock was trading at $0.40 at the beginning of 2025. Since then, VODG stock has increased by 0.0% and is now trading at $0.40.
View the best growth stocks for 2025 here
.

Shares of VODG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vitro Diagnostics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), American Battery Technology (ABML), Biogen (BIIB), Devon Energy (DVN), Processa Pharmaceuticals (PCSA) and Akero Therapeutics (AKRO).

Company Calendar

Today
6/01/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:VODG
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.87 million
Net Margins
-531.95%
Pretax Margin
-532.00%

Debt

Sales & Book Value

Annual Sales
$1.86 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:VODG) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners